Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

4.7%

2 terminated/withdrawn out of 43 trials

Success Rate

94.3%

+7.8% vs industry average

Late-Stage Pipeline

5%

2 trials in Phase 3/4

Results Transparency

3%

1 of 33 completed trials have results

Key Signals

3 recruiting1 with results

Enrollment Performance

Analytics

N/A
11(68.8%)
Phase 2
2(12.5%)
Phase 1
1(6.3%)
Phase 4
1(6.3%)
Phase 3
1(6.3%)
16Total
N/A(11)
Phase 2(2)
Phase 1(1)
Phase 4(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (43)

Showing 20 of 43 trials
NCT01397669Not ApplicableRecruiting

Characteristics of Immunity in Gut Mucosa, Spinal Fluid, Lymph Node and Blood of HIV Negative Thais and Thais With HIV Infection

Role: collaborator

NCT00796146Recruiting

Establish and Characterize an Acute HIV Infection Cohort in a High Risk Population

Role: collaborator

NCT04505501Phase 2Active Not Recruiting

Reducing HIV Persistence in Lymph Nodes by Interleukin-15 (IL-15) Receptor Super-agonist (N-803) in Acute HIV Infection

Role: lead

NCT04413708Not ApplicableCompleted

mHealth Technologies to Enhance PrEP Adherence Among Thai MSM

Role: collaborator

NCT03745495Completed

HIV Self-Testing AND Uptake and Retention of PrEP Among Older Adolescent MSM and TGW

Role: lead

NCT05323695Not ApplicableCompleted

Implementation of a Depression Screening Intervention at a Transgender Health Clinic in Thailand

Role: lead

NCT03580512Completed

Study to Evaluate the Feasibility of Integrating the Point-of-care Testing for Sexually Transmitted Infections and HIV Into Community-based Clinics for MSM and TGW in Thailand

Role: lead

NCT01634477Completed

Trends of Morbidity and Mortality Among Thai HIV-infected and HIV-uninfected Patients: a Five-year Prospective Cohort Study

Role: lead

NCT03049371Not ApplicableCompleted

Exploration of the Neo-Vagina Study

Role: lead

NCT04593680Not ApplicableActive Not Recruiting

Assessment of Drug-drug Interactions Between Masculinizing Hormone Therapy and Antiretroviral Agents Concomitantly for Pre-exposure Prophylaxis Among Transgender Men

Role: lead

NCT03216798Completed

Client and Provider Preferences for HIV Care

Role: lead

NCT03203265Not ApplicableCompleted

Innovative Strategy to Offer Online Test and Treat for Thai MSM/TG

Role: lead

NCT04032028Active Not Recruiting

Same-Day Antiretroviral Therapy Initiation

Role: lead

NCT04383769Completed

Differentiated Service Delivery for Antiretroviral Therapy

Role: lead

NCT03032575Not ApplicableCompleted

Anal HPV Infection and Risk for Anal High-grade Squamous Intraepithelial Lesion Among Thai MSM With Acute HIV Infection

Role: lead

NCT02437981Enrolling By Invitation

Evaluation of PrEP-30: a Demonstration Project of Pre-exposure Prophylaxis for MSM and Other High-risk Group Clients at the Thai Red Cross Anonymous Clinic

Role: lead

NCT02155231Completed

Study on Anal Human Papillomavirus Infection and Anal Intraepithelial Neoplasia Among Men Who Have Sex With Men in Indonesia, Malaysia, and Thailand

Role: lead

NCT01869595Completed

Thai MSM/TG Test and Treat Study

Role: lead

NCT04590417Not ApplicableActive Not Recruiting

Assessment of Drug-drug Interactions Between Feminizing Hormone Therapy and Emtricitabine/Tenofovir Alafenamide Concomitantly for Pre-exposure Prophylaxis Among Transgender Women

Role: lead

NCT05350865Recruiting

Thailand HDV Cohort

Role: collaborator